Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DataMEDS AIMEDS -3.35% PS Ratio is 0.32 as of Jul. 26, 2026, which is 69% below its 10-year median of 1.04. The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, DataMEDS AI ranks better than 58.82% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, DataMEDS AI's share price is $3.17.
DataMEDS AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $9.95. Hence, DataMEDS AI's PS Ratio for today is 0.32.
The historical rank and industry rank for DataMEDS AI's PS Ratio or its related term are showing as below:
MEDS'
s PS Ratio Range Over the Past 10 Years
Min: 0.26 Med: 1.04 Max: 14.21
Current: 0.32
During the past 4 years, DataMEDS AI's highest PS Ratio was 14.21. The lowest was 0.26. And the median was 1.04.
MEDS's PS Ratio is ranked better than 58.82% of 119
companies
in the Medical Distribution industry
Industry Median: 0.4
vs MEDS: 0.32
DataMEDS AI Inc revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of DataMEDS AI was -64.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -22.00% per year.
During the past 4 years, DataMEDS AI's highest 3-Year average Revenue per Share Growth Rate was -22.00% per year. The lowest was -22.00% per year. And the median was -22.00% per year.
Back to Basics: PS Ratio
DataMEDS AI (NAS:MEDS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
DataMEDS AI PS Ratio Related Terms
DataMEDS AI PS Ratio Historical Data
* Premium members only.
The historical data trend for DataMEDS AI's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, DataMEDS AI's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DataMEDS AI PS Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, DataMEDS AI's PS Ratio distribution charts can be found below:
* The bar in red indicates where DataMEDS AI's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
DataMEDS AI's Share Price of today is $3.17. DataMEDS AI's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $9.95.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
DataMEDS AI (MEDS) has a PS Ratio of 0.32 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on DataMEDS AI and its competitors. This is 69% below median its historical median of 1.04. Over the past decade, DataMEDS AI's PS Ratio has ranged from 0.26 to 14.21. According to the industry distribution chart, DataMEDS AI ranks #49 out of 119 companies in the Medical Distribution industry, placing it in the top 41.2%.
Is DataMEDS AI's PS Ratio too high?
DataMEDS AI's current PS Ratio of 0.32 is 69% below median its 10-year median of 1.04. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 14.21. The Medical Distribution industry median PS Ratio is 0.40. DataMEDS AI's value of 0.32 is 20% below this industry median. Based on the distribution chart, DataMEDS AI ranks #49 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint.
How does DataMEDS AI's PS Ratio compare to HEWA and BLMH?
According to the Medical Distribution industry distribution chart, DataMEDS AI ranks #49 out of 119 companies for PS Ratio. This puts DataMEDS AI in the upper half of its industry. The industry median PS Ratio is 0.40. DataMEDS AI's value of 0.32 is 20% below this benchmark. Historically, DataMEDS AI's own PS Ratio has ranged from 0.26 to 14.21 over the past decade. While the company's 10-year median is 1.04 vs. the industry median of 0.40, DataMEDS AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Distribution company?
The median PS Ratio among Medical Distribution companies is 0.40, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DataMEDS AI's current PS Ratio of 0.32 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on DataMEDS AI and its competitors. For the Medical Distribution industry, the median PS Ratio is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DataMEDS AI's current PS Ratio is 0.32, which is 69% below median its own 10-year median of 1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DataMEDS AI stock overvalued right now?
DataMEDS AI (MEDS) has a current PS Ratio of 0.32. The current PS Ratio is 0.32, which is 69% below median its 10-year median of 1.04 and 20% below the Medical Distribution industry median of 0.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For DataMEDS AI (MEDS), the current PS Ratio is 0.32 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. The company seeks to be a micro health ecosystem, with a portfolio comprising a pharmacy, wholesale operations, and a technology division that provides a novel platform for hub and clinical services. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDS has been successfully added to your 
